David A. GiljohannChief Executive Officer | Skokie, Illinois
Dr. Giljohann has served as Exicure’s Chief Executive Officer since November 2013 and been on its board of directors since March 2014. From July 2012 to October 2013, Dr. Giljohann was Exicure’s Chief Operating Officer and its founding scientist in 2011. From 2011 to June 2012, Dr. Giljohann served as the company’s principal scientist. Prior to that, Dr. Giljohann was the founding scientist of AuraSense, LLC in 2009.
Dr. Giljohann completed his Ph.D. in the laboratory of Dr. Chad A. Mirkin where he developed oligonucleotide-modified nanoparticles, including NanoFlare™, and spherical nucleic acid constructs. Dr. Giljohann has been recognized for his work with a Materials Research Society Gold Award, Baxter Innovation Award, Rappaport Award for Research Excellence, NSEC Outstanding Research Award, and as a finalist in the National Inventors Hall of Fame Collegiate Inventors Competition.